On this episode of the CEO Podcast, Clint sat down with Will Lewis, the CEO of Innsmed, a company dedicated to developing innovative drugs for patients facing serious and rare diseases. Will shares his journey to becoming CEO, the transformative growth of Innsmed, and the intricate process of drug development, including the lengthy timelines and significant financial investments involved. They discuss the importance of patient experience, the ethical considerations in drug development, and the role of artificial intelligence in streamlining processes. Will also offers insights into leadership, mentorship, and the values that drive his team to make a meaningful difference in patients' lives. Timestamps:00:00 - Introduction to Innsmed and CEO Journey00:38 - Overview of Innsmed's Mission01:39 - The Drug Development Process04:04 - The Necessity of the 15-Year Process06:38 - Expedited Drug Development During COVID-1908:12 - Choosing Which Diseases to Target10:51 - The Future of Curing Diseases12:55 - The Role of Artificial Intelligence in Drug Development16:21 - A Day in the Life of the CEO18:05 - Leadership Philosophy and Values20:18 - Reading Recommendations21:22 - Impact of the Macro Economic Environment24:02 - Financing in the Biotech Industry27:03 - Intellectual Property and Competition30:37 - Closing Thoughts on Mentorship and Opportunities

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related